Registered Trials
-
NCT05405283
Phase 3France
Total Enrollment: 178
Official Trial Registration:
-
NCT05124171, EUCTR2021-004550-33
Phase 3France
Total Enrollment: 300
Official Trial Registration:
Vaccine Type: Protein Subunit
This vaccine may also be referred to as CoV2 preS dTM adjuvanted vaccine (B.1.351)
This vaccine has reached Phase 3 trials.
There are no trials for this phase.
There are no trials for this phase.
This vaccine is not yet approved.
France
Total Enrollment: 178
France
Total Enrollment: 300
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.